Subcutaneous implantable cardioverter-defibrillator (SICD) for sudden cardiac death - A case series

Abstract

Sudden cardiac death is the final event caused in several cases by ventricular arrhythmias. Transvenous implantable cardioverter-defibrillators have been the standard therapy for the prevention of sudden cardiac death. The most frequent complications associated with TV-ICD is related to intracavitary electrodes. S-ICD has been developed as an alternative system. Novel S-ICD device in prevention of SCA was implanted in 8 patients with an average follow up period of 2.5 years. Bleeding and inappropriate shock was reported in one patient. Appropriate shock for ventricular tachycardia was observed in 5 patients. There was no death reported in any of the patients.